Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedMay 22, 2026
DataAggregated Company Financials
Companies23
  • 7D2.7%
  • 3M-2.0%
  • 1Y-8.2%
  • YTD-16.4%

The Pharma industry is up 2.7% in the last week, with Camurus up 3.2%. Meanwhile, Dicot Pharma actually underperformed within the industry, shrinking 19% in the last week. However, the industry is down 8.2% over the past year. Earnings are forecast to grow by 37% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 22 May 2026SEK 43.8bSEK 5.3b-SEK 1,301,575,145.0067.2x-33.6x8.3x
Sun, 19 Apr 2026SEK 47.5bSEK 5.4b-SEK 1,189,677,671.0064.4x-40x8.8x
Tue, 17 Mar 2026SEK 40.7bSEK 5.3b-SEK 1,377,968,671.0054.9x-29.5x7.7x
Thu, 12 Feb 2026SEK 52.1bSEK 5.3b-SEK 1,472,880,873.0054.8x-35.4x9.8x
Sat, 10 Jan 2026SEK 52.7bSEK 5.3b-SEK 531,735,157.0073.1x-99.1x9.9x
Mon, 08 Dec 2025SEK 48.9bSEK 5.3b-SEK 531,735,157.0069.3x-91.9x9.2x
Wed, 05 Nov 2025SEK 50.0bSEK 5.2b-SEK 539,421,865.0071.1x-92.7x9.6x
Fri, 03 Oct 2025SEK 54.5bSEK 5.1b-SEK 405,183,865.0069.6x-134.6x10.7x
Sun, 31 Aug 2025SEK 57.9bSEK 5.1b-SEK 405,542,865.0079.1x-142.8x11.4x
Tue, 29 Jul 2025SEK 56.9bSEK 5.0b-SEK 375,088,364.0077.6x-151.7x11.3x
Thu, 26 Jun 2025SEK 50.2bSEK 4.8b-SEK 574,548,822.8566.6x-87.4x10.4x
Sat, 24 May 2025SEK 44.2bSEK 4.8b-SEK 597,077,173.5959.8x-74x9.1x
Mon, 21 Apr 2025SEK 47.4bSEK 4.7b-SEK 911,478,077.3967.5x-52.1x10.1x
Wed, 19 Mar 2025SEK 49.9bSEK 4.7b-SEK 809,523,720.0571.3x-61.6x10.6x
Fri, 14 Feb 2025SEK 52.3bSEK 4.5b-SEK 1,004,609,319.28134.9x-52.1x11.6x
Sun, 12 Jan 2025SEK 51.5bSEK 4.4b-SEK 615,786,090.60132.8x-83.7x11.6x
Tue, 10 Dec 2024SEK 51.3bSEK 4.4b-SEK 615,903,230.96134.5x-83.2x11.5x
Thu, 07 Nov 2024SEK 51.6bSEK 4.3b-SEK 682,051,991.96136x-75.6x11.9x
Sat, 05 Oct 2024SEK 65.7bSEK 5.9b-SEK 1,157,224,367.43166.7x-56.8x11.2x
Mon, 02 Sep 2024SEK 70.8bSEK 5.9b-SEK 1,166,314,026.00187.7x-60.7x12x
Wed, 31 Jul 2024SEK 68.1bSEK 5.6b-SEK 992,910,255.8697x-68.6x12.2x
Fri, 28 Jun 2024SEK 65.2bSEK 6.4b-SEK 862,467,281.0777.3x-75.6x10.2x
Sun, 26 May 2024SEK 53.3bSEK 6.4b-SEK 766,510,517.9371.7x-69.5x8.4x
Tue, 23 Apr 2024SEK 48.1bSEK 6.2b-SEK 1,040,638,863.1076.1x-46.2x7.7x
Thu, 21 Mar 2024SEK 50.7bSEK 6.2b-SEK 1,038,080,642.9176x-48.9x8.1x
Sat, 17 Feb 2024SEK 47.2bSEK 6.1b-SEK 931,676,075.2958.7x-50.6x7.7x
Mon, 15 Jan 2024SEK 73.1bSEK 9.5b-SEK 1,182,119,507.0071.1x-61.9x7.7x
Wed, 13 Dec 2023SEK 63.9bSEK 9.4b-SEK 1,184,548,480.0058.4x-54x6.8x
Fri, 10 Nov 2023SEK 56.7bSEK 9.3b-SEK 1,283,149,467.0090x-44.2x6.1x
Sun, 08 Oct 2023SEK 51.2bSEK 9.2b-SEK 1,180,572,714.00116.3x-43.4x5.6x
Tue, 05 Sep 2023SEK 51.1bSEK 9.2b-SEK 1,177,918,104.00139.4x-43.4x5.6x
Thu, 03 Aug 2023SEK 51.2bSEK 8.9b-SEK 1,414,189,135.0087.5x-36.2x5.7x
Sat, 01 Jul 2023SEK 47.4bSEK 8.4b-SEK 1,692,681,920.0072.9x-28x5.7x
Mon, 29 May 2023SEK 49.5bSEK 8.4b-SEK 1,592,308,240.0076.5x-31.1x5.9x
Price to Earnings Ratio

-31.1x


Total Market Cap: SEK 49.5bTotal Earnings: -SEK 1,592,308,240.00Total Revenue: SEK 8.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -74x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 9.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 14% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market1.92%
Healthcare3.56%
Pharma2.73%
Pharma2.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 525.503.1%
+SEK 956.0m		3.8%PE46x
SECARE SwedencareSEK 27.208.8%
+SEK 351.7m		-28.2%PE88.2x
ORX OrexoSEK 19.927.8%
+SEK 50.3m		28.7%PS39.1x
ERMA Enorama PharmaSEK 0.4556.3%
+SEK 12.0m		-84.4%PS12.2x
ONCOZ OncoZengeSEK 7.2812.3%
+SEK 11.2m		41.4%PS36.7x

Latest News

ORX
SEK 19.92
Orexo
7D
7.8%
1Y
28.7%
SECARE
SEK 27.20
Swedencare
7D
8.8%
1Y
-28.2%
DICOT
SEK 0.21
Dicot Pharma
7D
-12.3%
1Y
-51.7%
CAMX
SEK 525.50
Camurus
7D
3.1%
1Y
3.8%
Analysis Article • May 20

The Strong Earnings Posted By Camurus (STO:CAMX) Are A Good Indication Of The Strength Of The Business

Investors were underwhelmed by the solid earnings posted by Camurus AB (publ) ( STO:CAMX ) recently. Our analysis says...
MOB
SEK 10.42
Moberg Pharma
7D
-7.3%
1Y
19.8%
CINPHA
SEK 12.14
Cinclus Pharma Holding
7D
-0.8%
1Y
-22.9%
ERMA
SEK 0.45
Enorama Pharma
7D
56.3%
1Y
-84.4%
ENZY
SEK 2.43
Enzymatica
7D
-2.8%
1Y
-21.1%
ANNX
SEK 13.55
Annexin Pharmaceuticals
7D
-10.3%
1Y
-62.4%
DBP B
SEK 0.12
Double Bond Pharmaceutical International
7D
9.1%
1Y
-72.7%
IBT B
SEK 55.60
Infant Bacterial Therapeutics
7D
-2.5%
1Y
-4.0%
Analysis Article • Apr 20

We're Hopeful That Infant Bacterial Therapeutics (STO:IBT B) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
FLERIE
SEK 23.90
Flerie
7D
-3.2%
1Y
-38.0%
ACUC
SEK 0.76
AcuCort
7D
2.0%
1Y
-9.9%
KLAR
SEK 0.79
Klaria Pharma Holding AB (publ.)
7D
-17.3%
1Y
-5.9%
ONCOZ
SEK 7.28
OncoZenge
7D
12.3%
1Y
41.4%
ODI
SEK 3.88
ODI Pharma
7D
1.6%
1Y
50.4%